Centessa Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	Jul '25 Jul 15, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019
Market Capitalization	1,554	1,764	610	243	748	-	Upgrade
Market Cap Growth	65.17%	189.13%	150.68%	-67.44%	-	-	Upgrade
Enterprise Value	1,430	1,418	455	-69	320	-	Upgrade
Last Close Price	11.34	12.71	-	-	-	-	Upgrade
PS Ratio	133.85	-	113.40	-	-	-	Upgrade
PB Ratio	5.20	5.50	3.29	0.87	2.06	-	Upgrade
P/TBV Ratio	5.20	5.50	3.29	0.87	2.06	-	Upgrade
EV/Sales Ratio	128.31	-	84.53	-	-	-	Upgrade
Debt / Equity Ratio	0.31	0.29	0.36	0.21	0.15	1.82	Upgrade
Asset Turnover	0.04	-	0.02	-	-	-	Upgrade
Quick Ratio	13.93	9.10	7.51	10.97	24.84	1.18	Upgrade
Current Ratio	14.37	9.25	8.00	11.42	25.52	1.30	Upgrade
Return on Equity (ROE)	-74.44%	-73.93%	-52.79%	-52.24%	-154.41%	-	Upgrade
Return on Assets (ROA)	-28.58%	-26.82%	-26.61%	-24.48%	-27.16%	-	Upgrade
Return on Capital (ROIC)	-30.38%	-29.91%	-29.46%	-27.01%	-30.24%	-	Upgrade
Earnings Yield	-11.15%	-10.67%	-19.44%	-73.73%	-37.73%	-	Upgrade
FCF Yield	-8.07%	-6.43%	-20.65%	-68.77%	-13.47%	-	Upgrade
Buyback Yield / Dilution	-26.02%	-19.02%	-2.97%	-24.26%	-401.11%	-	Upgrade

Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.